Sort
11,323 grants matching “glioblastoma”
Improved Diagnostics and Individualized Therapeutics using Optical Microring Reso
$37,667Nicole Villiere Tolan · University Of Illinois At Urbana-Champaign · F32 · FY2010 · CA
Mechanisms of the TFIIH-associated kinase CDK7 in p53-dependent transcriptional regulation
$37,654Jenna Kathleen Rimel · University Of Colorado · F31 · FY2020 · CA
Genomic approaches to guide molecular classification of glioma
$37,644Bill H Diplas · Duke University · F30 · FY2017 · CA
Investigating the role of CARM1-mediated methylation of Qki in glioblastoma
$37,598Kaylene Jiayi Lu · University Of Tx Md Anderson Can Ctr · F31 · FY2025 · CA
MET kinase fusions in pediatric glioblastoma
$37,560Renee D Read · Emory University · R21 · FY2023 · NS
Elucidating Signatures of DNA Damage Response Alterations from Structural Variants in Human Cancer
$37,547Gregory Raskind · Harvard Medical School · F31 · FY2025 · CA
Monosynaptic tracing defines circuit connectivity of human high-grade glioma in the adult mouse brain
$37,543Yusha Sun · University Of Pennsylvania · F31 · FY2025 · NS
Identification of Small Molecule Inhibitors of PHF5A for Glioblastoma
$37,474Marc Ferrer · National Center For Advancing Translational Sciences · ZIA · FY2016 · TR
The role of IDO and Th17 in an experimental mouse model of glioma
$37,411Derek Alan Wainwright · University Of Chicago · F32 · FY2012 · NS
HIV NCp7 inhibitors and Multivalent Inhibition of Membrane Receptors
$37,395Stewart Durell · Division Of Basic Sciences - Nci · ZIC · FY2023 · CA
Screening strategy for small molecules inhibitors of cancer
$37,375Paul B Fisher · Virginia Commonwealth University · R03 · FY2012 · MH
Screening strategy for small molecules inhibitors of cancer
$37,375Paul B Fisher · Virginia Commonwealth University · R03 · FY2011 · MH
Next-generation Ligand-dependent Transcriptional Switch Receptors for the Control and Customization of Cell Therapeutics
$37,283Iowis Zhu · University Of California, San Francisco · F30 · FY2020 · CA
GABPB1L-mediated activation of the mutant TERT promoter as a therapeutic target in glioblastoma
$37,249Andrew G Mancini · University Of California, San Francisco · F99 · FY2017 · CA
Polyamines drive glioblastoma progression
$37,225Kristen Kay · Cleveland Clinic Lerner Com-Cwru · F31 · FY2021 · CA
Elucidating Reversible Drug Resistance in Glioblastoma
$37,180Fadi John Najm · Harvard Medical School · F31 · FY2018 · CA
Genomic approaches to guide molecular classification of glioma
$37,176Bill H Diplas · Duke University · F30 · FY2016 · CA
Single cell analysis and live imaging of tissue stem cells and cancer initiating cells
$37,132Chi Zhang · University Of Colorado · F99 · FY2021 · CA
The oncogenic functions of Neuropilin-1 in the glioblastoma tumor microenvironment
$37,117Daniel Radin · State University New York Stony Brook · F30 · FY2022 · CA
The Function of LINC00263 in Human Glioma
$37,106David Wu · University Of California, San Francisco · F31 · FY2019 · NS
ATM as target for malignant glioma radiosensitization.
$37,096Kristoffer Valerie · Virginia Commonwealth University · R01 · FY2011 · NS
Therapeutic Engineered Stem Cells as a New Adjuvant Therapy for Non-Small Cell Lung Cancer Brain Metastases
$37,027Alison R. Mercer-Smith · Univ Of North Carolina Chapel Hill · F30 · FY2020 · CA
Biomarker, Bioinformatics and Biorepository Core
$36,985Roger E McLendon · Duke University · U19 · FY2024 · CA
Elucidating Signatures of DNA Damage Response Alterations from Structural Variants in Human Cancer
$36,983Gregory Raskind · Harvard Medical School · F31 · FY2024 · CA
Inference of variable chromatin loops in glioblastoma tumors and single-cells
$36,961Caleb Andrew Lareau · Harvard Medical School · F31 · FY2018 · CA